Study: Low Protein Intake Linked to Kidney Failure Risk in CKD
Low daily protein intake fails to protect kidney function and increases the risk of kidney failure requiring replacement therapy and all-cause mortality among patients with chronic kidney disease, according to a study published in JAMA Network Open.
-
Key Clinical Takeaways:
- Patients with non-dialysis chronic kidney disease consuming less than 0.6 grams of protein per kilogram daily faced a significantly higher risk of kidney failure than those consuming higher amounts.
- The longitudinal study tracked 1,861 participants from nine tertiary hospitals in South Korea over a median follow-up period of 9.3 years.
- Researchers observed a nonlinear association, noting that kidney failure risk escalated sharply when daily protein intake fell below the cohort median of 0.945 grams per kilogram.
Evaluation of Dietary Protein and Kidney Failure Risk in Chronic Kidney Disease
For decades, dietary protein restriction has served as a cornerstone of conservative treatment for patients suffering from chronic kidney disease. The biological rationale rests on the premise that protein serves as a primary source of uremic toxins and metabolic acidosis, which together drive intraglomerular hypertension and accelerate kidney injury. Early clinical interest was bolstered by the Modification of Diet in Renal Disease study, prompting long-standing advocacy for a daily protein intake ranging from 0.6 to 0.8 grams per kilogram for patients with nondialysis chronic kidney disease.
However, the actual clinical benefit of strict protein restriction within contemporary care remains contentious. To investigate these long-term outcomes in an Asian population characterized by lower body mass and muscle reserves, investigators utilized data from the Korean Cohort Study for Outcomes in Patients With Chronic Kidney Disease, known as KNOW-CKD. Participants with chronic kidney disease stages ranging from 1 to predialysis 5 were enrolled between 2011 and 2016 across nine tertiary hospitals in South Korea. The study observation period concluded on January 31, 2024, with data analysis performed from February 2024 to May 2026.
Analysis of Urinary Nitrogen and Survival Outcomes
Daily protein intake was objectively estimated using 24-hour urinary nitrogen excretion measured at baseline. The study cohort was divided by researchers into five distinct categories: daily amounts under 0.6, from 0.6 up to 0.8, from 0.8 up to 1.0, from 1.0 up to 1.2, and 1.2 grams per kilogram or more. The primary outcome was the onset of kidney failure requiring replacement therapy, while secondary outcomes encompassed all-cause mortality and major adverse cardiovascular events.
Among the 1,861 analyzed participants with a mean age of 53.7 years, where 61.1 percent were male, the lowest daily protein intake group consuming less than 0.6 grams per kilogram daily showed a significantly higher risk of kidney failure requiring replacement therapy with a subdistribution hazard ratio of 1.42 compared to the highest intake group. All-cause mortality was also elevated in the lowest intake group with a subdistribution hazard ratio of 2.17. Conversely, the risk of major adverse cardiovascular events did not differ significantly across the intake groups. A spline analysis confirmed a nonlinear association, with the risk of kidney failure increasing sharply as intake decreased below the cohort median of 0.945 grams per kilogram daily.
The observed association held steady in sensitivity analyses that excluded participants who reached kidney failure within one year and those displaying markers of protein-energy wasting, such as serum albumin below 3.5 grams per deciliter or total cholesterol below 115 milligrams per deciliter. In a propensity score-matched cohort balanced for chronic kidney disease stage and albuminuria, the lowest intake group again demonstrated an increased risk of kidney failure with a subdistribution hazard ratio of 1.52. These findings remained consistent across subgroups, including stratified analyses by diabetes status.
Current clinical guidance regarding protein intake in chronic kidney disease has diverged across major organizations. For metabolically stable adults with chronic kidney disease stages 3 to 5 who do not have diabetes, a low-protein diet providing 0.55 to 0.60 grams per kilogram daily is advised by the 2020 Kidney Disease Outcomes Quality Initiative nutrition guideline. In contrast, the 2024 Kidney Disease: Improving Global Outcomes guideline suggests 0.8 grams per kilogram daily for adults with chronic kidney disease G3 to G5 while advising against intake exceeding 1.3 grams per kilogram daily for adults at risk of progression.
Study authors noted that their findings support a shift toward normalized protein intake and advocated for individualized dietary management. This approach weighs nutritional status and body composition alongside the reduction of kidney workload. For clinical pharmacists, the data reinforce the importance of screening chronic kidney disease patients regarding their eating habits, particularly individuals who reduce protein consumption independently. Signs of declining nutritional status warrant prompt referral to a renal dietitian or the patient’s nephrology team rather than encouraging further dietary restriction.
Several limitations qualify the findings of the study. The observational design prevents the establishment of causation, and the exclusively Korean cohort may limit generalizability to other populations. Daily protein intake was calculated from a single baseline urine collection, while total caloric intake and the specific differentiation between plant versus animal protein sources could not be assessed. Baseline enrollment predated the widespread clinical adoption of modern kidney-protective agents, including sodium-glucose cotransporter 2 inhibitors.
The long-term benefits of protein restriction on clinical outcomes in populations with lower baseline muscle mass and reserves remain an open question requiring further prospective evaluation.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.